Pluribus Labs, LLC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Pluribus Labs, LLC on CME, newest first. How the timeline and the estimate are built.

Pluribus Labs, LLC held 1,192 CME shares at 2022-06-30 per its 13F-HR filed 2022-08-12.

the latest 13F is the newest step

period ended2022-06-30
13F 1,192 shares
Change vs previous 13F +328 shares
0.45% of the 13F portfolio, value $244,000.
13F-HR 0001637714-22-000010 filed by Pluribus Labs, LLC
Filed 2022-08-12 (acceptance time not in the bulk data set), ingested 2026-10-07 18:35:03 UTC
Acceptance time not in the bulk data set (spec §4.2).
period ended2022-03-31
13F 864 shares
Change vs previous 13F not available
0.82% of the 13F portfolio, value $206,000.
13F-HR 0001637714-22-000004 filed by Pluribus Labs, LLC
Filed 2022-05-16 (acceptance time not in the bulk data set), ingested 2026-10-07 18:35:57 UTC
Acceptance time not in the bulk data set (spec §4.2).